Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT03014544 Completed - Clinical trials for Depressive Disorder, Major

Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)

Start date: October 26, 2016
Phase:
Study type: Observational

The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner‑administered cognitive tests.

NCT ID: NCT03013400 Completed - Bipolar Disorder Clinical Trials

Ebselen as an add-on Treatment in Hypo/Mania

Start date: October 1, 2017
Phase: Phase 2
Study type: Interventional

This study evaluates the effect of a 'lithium like' drug called ebselen (SP-1005) versus placebo as an 'add on' treatment to help stabilise hypo/manic symptoms in bipolar disorder. Half of the participants will receive ebselen and the other half placebo. The trial, will last a total of four weeks.

NCT ID: NCT03012724 Recruiting - Clinical trials for Major Depressive Disorder (MDD)

Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

Start date: March 30, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate that the efficacy and safety of deep brain rTMS, (Transcranial Magnetic Stimulation) H7-Coil treatment as add on treatment, is as good as the FDA cleared, H1-Coil, in subjects with major depressive disorder that have been previously unsuccessfully treated with antidepressant medications.

NCT ID: NCT03012594 Completed - Intestinal Disease Clinical Trials

Lanreotide in the Treatment of Small Bowel Motility Disorders

Start date: May 11, 2017
Phase: Phase 2
Study type: Interventional

This is a human research study looking at the effectiveness of Lanreotide (study medication) in treating small bowel motility disorders. It is similar to a natural hormone somatostatin that is produced in the body in the stomach, duodenum, pancreas and brain. Somatostatin is a growth hormone-inhibiting hormone. Lanreotide is a man made hormone and is a long acting medication that is given once a month. It is marketed with a trade name "Somatuline Depot". It is given deep subcutaneously (deep within the layers of the skin) in the superior external quadrant of the buttock. Injection site will be alternated on subsequent injections.

NCT ID: NCT03008486 Completed - Stroke Clinical Trials

Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness

Start date: January 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the effects on upper limb spasticity of soft splints worn during three weeks three hours a day by patients with stroke or disorders of consciousness.

NCT ID: NCT03007394 Completed - Clinical trials for Cocaine-Related Disorders

Lorcaserin in the Treatment of Cocaine Use Disorder

Start date: December 19, 2017
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

NCT ID: NCT03005574 Recruiting - Schizophrenia Clinical Trials

Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if using a tablet computer, which is a very small, easy-to-carry computer, to practice thinking exercises at home will help improve your attention, memory, and problem solving abilities. All the participants will receive training in the thinking skills for work program. But in order to determine the effect of tablet use for home practice, half of the participants will be given a tablet to practice the thinking exercises at home. All participants will be receiving vocational rehabilitation and have a goal of getting a job.

NCT ID: NCT03004872 Completed - Depression Clinical Trials

Relationship Between Postpartum Mood Disorders and Delivery Experience

Start date: October 31, 2016
Phase:
Study type: Observational

The purpose of this study is to evaluate potential risk factors for developing postpartum depression or posttraumatic stress disorder during the first year postpartum in patients who have no preexisting history of PTSD or PPD.

NCT ID: NCT03003910 Completed - Eating Disorder Clinical Trials

Efficacy of a Positive Psychological Intervention in Patients With Eating Disorders

Start date: February 2013
Phase: N/A
Study type: Interventional

This study is aimed to test the efficacy of a positive psychological intervention for promoting positive emotions and optimistic thinking in eating disordered patients. Participants are randomly assigned to receive the positive intervention or the control condition, which consists on thinking about daily activities.

NCT ID: NCT03003286 Completed - Clinical trials for Autism Spectrum Disorder

Community Based Intervention for Children With ADHD and ASD

Start date: September 13, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a new treatment, Unstuck and On Target (UOT), works better, worse, or the same as the best treatment that is available now, Contingency Behavioral Management (CBM), for low income children with Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD).